Basic Information | Post buying leads | Suppliers |
Name |
1-(p-Chloro-α-phenylbenzyl)hexa-hydro-4-methyl-1h-1,4-diazepine dihydro chloride |
EINECS | N/A |
CAS No. | 1982-36-1 | Density | 1.122g/cm3 |
PSA | 6.48000 | LogP | 5.54670 |
Solubility | N/A | Melting Point |
227-228° |
Formula | C19H23 Cl N2 . 2 Cl H | Boiling Point | 403.9°Cat760mmHg |
Molecular Weight | 387.81 | Flash Point | 198.1°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by ingestion, subcutaneous, intravenous, and intraperitoneal routes. When heated to decomposition it emits very toxic fumes of Cl− and NOx. | Risk Codes | 20/21/22 |
Molecular Structure | Hazard Symbols | ||
Synonyms |
1H-1,4-Diazepine,1-(p-chloro-a-phenylbenzyl)hexahydro-4-methyl-,dihydrochloride (6CI,7CI,8CI); 1H-1,4-Diazepine,1-[(4-chlorophenyl)phenylmethyl]hexahydro-4-methyl-, dihydrochloride (9CI);1-((4-Chlorophenyl)(phenyl)methyl)-4-methyl-1,4-diazacycloheptanedihydrochloride; Homochlorcyclizine, hydrochloride; NSC 169498; SA 97dihydrochloride |
IUPAC Name: 1-[(4-Chlorophenyl)-phenyl-methyl]-4-methyl-1,4-diazepane-1,4-diium dichloride
Synonyms: 1-[(4-Chlorophenyl)(phenyl)methyl]-4-methyl-1,4-diazepane dihydrochloride ; 1H-1,4-Diazepine, 1- (p-chloro-.alpha.-phenylbenzyl)hexahydro-4-methyl-, dihydrochloride ; 1H-1,4-diazepine, 1-[(4-chlorophenyl)phenylmethyl]hexahydro-4-methyl-, hydrochloride (1:2) ; 1-(p-Chloro-alpha-phenylbenzyl)hexahydro-4-methyl-1H-1,4-diazepine, dihydrochloride
CAS NO:1982-36-1
Molecular Formula of 1-(p-Chloro-α-phenylbenzyl)hexa-hydro-4-methyl-1h-1,4-diazepine dihydro chloride (CAS NO.1982-36-1) : C19H25Cl3N2
Molecular Weight of 1-(p-Chloro-α-phenylbenzyl)hexa-hydro-4-methyl-1h-1,4-diazepine dihydro chloride (CAS NO.1982-36-1) :387.77
Molecular Structure of 1-(p-Chloro-α-phenylbenzyl)hexa-hydro-4-methyl-1h-1,4-diazepine dihydro chloride (CAS NO.1982-36-1) :
Flash Point: 198.1 °C
Enthalpy of Vaporization: 65.53 kJ/mol
Boiling Point: 403.9 °C at 760 mmHg
Vapour Pressure: 9.82E-07 mmHg at 25°C
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
cat | LD50 | intraperitoneal | 50mg/kg (50mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Journal of Allergy. Vol. 31, Pg. 237, 1960. |
dog | LD50 | intraperitoneal | 50mg/kg (50mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: EXCITEMENT BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Journal of Allergy. Vol. 31, Pg. 237, 1960. |
dog | LD50 | intravenous | 20mg/kg (20mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: ATAXIA GASTROINTESTINAL: NAUSEA OR VOMITING | Journal of Allergy. Vol. 31, Pg. 237, 1960. |
guinea pig | LD50 | intraperitoneal | 76mg/kg (76mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Journal of Allergy. Vol. 31, Pg. 237, 1960. |
guinea pig | LD50 | intravenous | 19mg/kg (19mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Journal of Allergy. Vol. 31, Pg. 237, 1960. |
guinea pig | LD50 | oral | 390mg/kg (390mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) BEHAVIORAL: ATAXIA | Journal of Allergy. Vol. 31, Pg. 237, 1960. |
mouse | LD50 | intraperitoneal | 125mg/kg (125mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: EXCITEMENT BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Journal of Allergy. Vol. 31, Pg. 237, 1960. |
mouse | LD50 | intravenous | 47mg/kg (47mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: ATAXIA BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Journal of Allergy. Vol. 31, Pg. 237, 1960. |
mouse | LD50 | oral | 390mg/kg (390mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: EXCITEMENT BEHAVIORAL: ATAXIA | Journal of Allergy. Vol. 31, Pg. 237, 1960. |
mouse | LD50 | subcutaneous | 135mg/kg (135mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) BEHAVIORAL: EXCITEMENT | Journal of Allergy. Vol. 31, Pg. 237, 1960. |
rabbit | LD50 | intravenous | 20mg/kg (20mg/kg) | BEHAVIORAL: TREMOR LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Journal of Allergy. Vol. 31, Pg. 237, 1960. |
rat | LD50 | intraperitoneal | 80mg/kg (80mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: EXCITEMENT | Journal of Allergy. Vol. 31, Pg. 237, 1960. |
rat | LD50 | intravenous | 36mg/kg (36mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION BEHAVIORAL: EXCITEMENT BEHAVIORAL: TREMOR | Journal of Allergy. Vol. 31, Pg. 237, 1960. |
rat | LD50 | oral | 490mg/kg (490mg/kg) | BEHAVIORAL: EXCITEMENT LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Journal of Allergy. Vol. 31, Pg. 237, 1960. |
Poison by ingestion, subcutaneous, intravenous, and intraperitoneal routes. When heated to decomposition it emits very toxic fumes of Cl− and NOx.
Hazard Codes Xn
Risk Statements 20/21/22
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed.
Safety Statements 36
S36:Wear suitable protective clothing.
WGK Germany 3
RTECS HM3675000